
LINK . SPRINGER . COM {
}
Title:
Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance | Gastric Cancer
Description:
Background The attainment of drug resistance in gastric cancer (GC) is a problematic issue. Although many studies have shown that cancer stem cells (CSCs) play an important role in the acquisition of drug resistance, there is no clinically available biomarker for predicting oxaliplatin (L-OHP) resistance in relation to CSCs. Organoid technology, a novel 3D cell culture system, allows harboring of patient-derived cancer cells containing abundant CSCs using niche factors in a dish. Methods In this study, we established L-OHP-resistant gastric cancer organoids (GCOs) and evaluated their gene expression profile using microarray analysis. We validated the upregulated genes in the L-OHP-resistant GCOs compared to their parental GCOs to find a gene responsible for L-OHP resistance by qRT-PCR, immunohistochemistry, in vitro, and in vivo experiments. Results We found myoferlin (MYOF) to be a candidate gene through microarray analysis. The results from cell viability assays and qRT-PCR showed that high expression of MYOF correlated significantly with the IC50 of L-OHP in GCOs. Immunohistochemistry of MYOF in GC tissue samples revealed that high expression of MYOF was significantly associated with poor prognosis, T grade, N grade, and lymphatic invasion, and showed MYOF to be an independent prognostic indicator, especially in the GC patients treated with platinum-based chemotherapy. The knockdown of MYOF repressed L-OHP resistance, cell growth, stem cell features, migration, invasion, and in vivo tumor growth. Conclusions Our results suggest that MYOF is highly involved in L-OHP resistance and tumor progression in GC. MYOF could be a promising biomarker and therapeutic target for L-OHP-resistant GC cases.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Education
- Science
- Health & Fitness
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We don’t know how the website earns money.
Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.
Keywords {🔍}
myof, gcos, lohp, cancer, expression, cell, fig, lohpresistant, cells, article, resistance, gastric, supplementary, google, scholar, analysis, organoids, tumor, assay, test, mkn, lines, cas, organoid, parental, invasion, patients, student, cscs, showed, cases, performed, gene, genes, results, growth, human, hiroshima, table, levels, data, research, myoferlin, shown, study, microarray, migration, normal, size, survival,
Topics {✒️}
r-spondin-producing cell line l-ohp-based therapeutic outcomes l-ohp-resistant gcos compared l-ohp-resistant gcos transduced k24 l-ohp-resistant gcos independent l-ohp-resistant gcos establish l-ohp-resistant gcos l-ohp-resistant gcos exhibited dna-damaging anti-cancer drugs k24 l-ohp-resistant gco l-ohp-resistant gc cases l-ohp-based treatment response stem cell-related markers patient-derived cancer cells exerts anti-tumor effects liver-intestine cadherin induction receiving platinum-based chemotherapy l-ohp-resistant gcos alter l-ohp sensitivity overcome l-ohp resistance approach l-ohp resistance reflects l-ohp resistance csc/epithelial-mesenchymal transition l-ohp-resistant gco received platinum-based chemotherapy receive platinum-based therapy dab substrate-chromogen solution human genome/gene research l-ohp administration timeline l-ohp treatment leads l-ohp gastric cscs l-ohp-resistant cscs drug-resistant cancer organoids cancer stem cell envision + anti-mouse full size image cancer stem cells phase-contrast microscopy anti-rabbit peroxidase triple-negative breast cancer l-ohp exerts cell stem cell organoid-based preclinical model elucidated 5-fu-resistant gcos kaplan–meier plotter database living organoid biobank human gastric cancer sustain stem cells gene expression profile l-ohp-resistant
Schema {🗺️}
WebPage:
mainEntity:
headline:Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance
description:The attainment of drug resistance in gastric cancer (GC) is a problematic issue. Although many studies have shown that cancer stem cells (CSCs) play an important role in the acquisition of drug resistance, there is no clinically available biomarker for predicting oxaliplatin (L-OHP) resistance in relation to CSCs. Organoid technology, a novel 3D cell culture system, allows harboring of patient-derived cancer cells containing abundant CSCs using niche factors in a dish. In this study, we established L-OHP-resistant gastric cancer organoids (GCOs) and evaluated their gene expression profile using microarray analysis. We validated the upregulated genes in the L-OHP-resistant GCOs compared to their parental GCOs to find a gene responsible for L-OHP resistance by qRT-PCR, immunohistochemistry, in vitro, and in vivo experiments. We found myoferlin (MYOF) to be a candidate gene through microarray analysis. The results from cell viability assays and qRT-PCR showed that high expression of MYOF correlated significantly with the IC50 of L-OHP in GCOs. Immunohistochemistry of MYOF in GC tissue samples revealed that high expression of MYOF was significantly associated with poor prognosis, T grade, N grade, and lymphatic invasion, and showed MYOF to be an independent prognostic indicator, especially in the GC patients treated with platinum-based chemotherapy. The knockdown of MYOF repressed L-OHP resistance, cell growth, stem cell features, migration, invasion, and in vivo tumor growth. Our results suggest that MYOF is highly involved in L-OHP resistance and tumor progression in GC. MYOF could be a promising biomarker and therapeutic target for L-OHP-resistant GC cases.
datePublished:2021-07-16T00:00:00Z
dateModified:2021-07-30T00:00:00Z
pageStart:1264
pageEnd:1277
sameAs:https://doi.org/10.1007/s10120-021-01206-4
keywords:
Organoids
Oxaliplatin
Gastric cancer
MYOF
Surgical Oncology
Oncology
Abdominal Surgery
Gastroenterology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig5_HTML.png
isPartOf:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:24
type:
Periodical
PublicationVolume
publisher:
name:Springer Singapore
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Kenji Harada
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Naoya Sakamoto
url:http://orcid.org/0000-0001-6273-0189
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Shoichi Ukai
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Yusuke Yamamoto
affiliation:
name:National Cancer Center Research Institute
address:
name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Quoc Thang Pham
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Daiki Taniyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Ririno Honma
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Ryota Maruyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Tsuyoshi Takashima
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroshi Ota
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Takemoto
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazuaki Tanabe
affiliation:
name:Hiroshima University
address:
name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Hideki Ohdan
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Wataru Yasui
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance
description:The attainment of drug resistance in gastric cancer (GC) is a problematic issue. Although many studies have shown that cancer stem cells (CSCs) play an important role in the acquisition of drug resistance, there is no clinically available biomarker for predicting oxaliplatin (L-OHP) resistance in relation to CSCs. Organoid technology, a novel 3D cell culture system, allows harboring of patient-derived cancer cells containing abundant CSCs using niche factors in a dish. In this study, we established L-OHP-resistant gastric cancer organoids (GCOs) and evaluated their gene expression profile using microarray analysis. We validated the upregulated genes in the L-OHP-resistant GCOs compared to their parental GCOs to find a gene responsible for L-OHP resistance by qRT-PCR, immunohistochemistry, in vitro, and in vivo experiments. We found myoferlin (MYOF) to be a candidate gene through microarray analysis. The results from cell viability assays and qRT-PCR showed that high expression of MYOF correlated significantly with the IC50 of L-OHP in GCOs. Immunohistochemistry of MYOF in GC tissue samples revealed that high expression of MYOF was significantly associated with poor prognosis, T grade, N grade, and lymphatic invasion, and showed MYOF to be an independent prognostic indicator, especially in the GC patients treated with platinum-based chemotherapy. The knockdown of MYOF repressed L-OHP resistance, cell growth, stem cell features, migration, invasion, and in vivo tumor growth. Our results suggest that MYOF is highly involved in L-OHP resistance and tumor progression in GC. MYOF could be a promising biomarker and therapeutic target for L-OHP-resistant GC cases.
datePublished:2021-07-16T00:00:00Z
dateModified:2021-07-30T00:00:00Z
pageStart:1264
pageEnd:1277
sameAs:https://doi.org/10.1007/s10120-021-01206-4
keywords:
Organoids
Oxaliplatin
Gastric cancer
MYOF
Surgical Oncology
Oncology
Abdominal Surgery
Gastroenterology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_Fig5_HTML.png
isPartOf:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:24
type:
Periodical
PublicationVolume
publisher:
name:Springer Singapore
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Kenji Harada
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Naoya Sakamoto
url:http://orcid.org/0000-0001-6273-0189
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Shoichi Ukai
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Yusuke Yamamoto
affiliation:
name:National Cancer Center Research Institute
address:
name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
type:PostalAddress
type:Organization
type:Person
name:Quoc Thang Pham
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Daiki Taniyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Ririno Honma
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Ryota Maruyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Tsuyoshi Takashima
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiroshi Ota
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Yuki Takemoto
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Kazuaki Tanabe
affiliation:
name:Hiroshima University
address:
name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Hideki Ohdan
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
name:Wataru Yasui
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Gastric Cancer
issn:
1436-3305
1436-3291
volumeNumber:24
Organization:
name:Springer Singapore
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:National Cancer Center Research Institute
address:
name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Kenji Harada
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Naoya Sakamoto
url:http://orcid.org/0000-0001-6273-0189
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
email:[email protected]
name:Shoichi Ukai
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Yusuke Yamamoto
affiliation:
name:National Cancer Center Research Institute
address:
name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
type:PostalAddress
type:Organization
name:Quoc Thang Pham
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Daiki Taniyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Ririno Honma
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Ryota Maruyama
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Tsuyoshi Takashima
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Hiroshi Ota
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Yuki Takemoto
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Kazuaki Tanabe
affiliation:
name:Hiroshima University
address:
name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Hideki Ohdan
affiliation:
name:Hiroshima University
address:
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
name:Wataru Yasui
affiliation:
name:Hiroshima University
address:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Health Care for Adults, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
name:Department of Molecular Pathology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
External Links {🔗}(121)
- Income figures for https://www.springernature.com/gp/authors
- How much profit is https://link.springernature.com/home/ making per month?
- What's the financial gain of https://order.springer.com/public/cart?
- What's https://www.editorialmanager.com/gcan's gross income?
- How much revenue does https://orcid.org/0000-0001-6273-0189 generate?
- Find out how much https://beta.springernature.com/pre-submission?journalId=10120 earns monthly
- Get to know what's the income of http://gepia.cancer-pku.cn
- What's the financial intake of http://www.kmplot.com?
- How much does http://gepia.cancer-pku.cn/ bring in each month?
- Find out how much https://doi.org/10.3322%2Fcaac.21492 earns monthly
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Global%20cancer%20statistics%202018%3A%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries&journal=CA%20Cancer%20J%20Clin&doi=10.3322%2Fcaac.21492&volume=68&pages=394-424&publication_year=2018&author=Bray%2CF&author=Ferlay%2CJ&author=Soerjomataram%2CI&author=Siegel%2CRL&author=Torre%2CLA&author=Jemal%2CA?
- What's the income generated by https://doi.org/10.1038%2Fnrc3599 each month?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Cancer%20drug%20resistance%3A%20an%20evolving%20paradigm&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc3599&volume=13&pages=714-26&publication_year=2013&author=Holohan%2CC&author=Schaeybroeck%2CS&author=Longley%2CDB&author=Johnston%2CPG generate?
- Learn how profitable https://doi.org/10.1038%2Fnrclinonc.2017.44 is on a monthly basis
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=EMT%2C%20CSCs%2C%20and%20drug%20resistance%3A%20the%20mechanistic%20link%20and%20clinical%20implications&journal=Nat%20Rev%20Clin%20Oncol&doi=10.1038%2Fnrclinonc.2017.44&volume=14&pages=611-629&publication_year=2017&author=Shibue%2CT&author=Weinberg%2CRA?
- Explore the financials of https://doi.org/10.1016%2Fj.cell.2014.12.021
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Organoid%20models%20of%20human%20and%20mouse%20ductal%20pancreatic%20cancer&journal=Cell&doi=10.1016%2Fj.cell.2014.12.021&volume=160&pages=324-38&publication_year=2015&author=Boj%2CSF&author=Hwang%2CC-I&author=Baker%2CLA&author=Chio%2CII&author=Engle%2CDD&author=Corbo%2CV
- What's the income generated by https://doi.org/10.1126%2Fscience.1247125 each month?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Organogenesis%20in%20a%20dish%3A%20modeling%20development%20and%20disease%20using%20organoid%20technologies&journal=Science&doi=10.1126%2Fscience.1247125&volume=345&publication_year=2014&author=Lancaster%2CMA&author=Knoblich%2CJA
- Check the income stats for https://doi.org/10.1136%2Fgutjnl-2017-314549
- http://scholar.google.com/scholar_lookup?&title=Human%20gastric%20cancer%20modelling%20using%20organoids&journal=Gut&doi=10.1136%2Fgutjnl-2017-314549&volume=68&pages=207-17&publication_year=2019&author=Seidlitz%2CT&author=Merker%2CSR&author=Rothe%2CA&author=Zakrzewski%2CF&author=Neubeck%2CC&author=Gr%C3%BCtzmann%2CK income
- How much cash flow does https://doi.org/10.1016%2Fj.stem.2018.09.016 have monthly?
- Get to know http://scholar.google.com/scholar_lookup?&title=A%20comprehensive%20human%20gastric%20cancer%20organoid%20biobank%20captures%20tumor%20subtype%20heterogeneity%20and%20enables%20therapeutic%20screening&journal=Cell%20Stem%20Cell&doi=10.1016%2Fj.stem.2018.09.016&volume=23&pages=882-97&publication_year=2018&author=Yan%2CHHN&author=Siu%2CHC&author=Law%2CS&author=Ho%2CSL&author=Yue%2CSSK&author=Tsui%2CWY's earnings
- How much profit does https://doi.org/10.1016%2Fj.jcmgh.2018.09.008 make?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=An%20organoid-based%20preclinical%20model%20of%20human%20gastric%20cancer&journal=Cell%20Mol%20Gastroenterol%20Hepatol&doi=10.1016%2Fj.jcmgh.2018.09.008&volume=7&pages=161-84&publication_year=2019&author=Steele%2CNG&author=Chakrabarti%2CJ&author=Wang%2CJ&author=Biesiada%2CJ&author=Holokai%2CL&author=Chang%2CJ?
- What's the financial outcome of https://doi.org/10.1016%2Fj.cell.2015.03.053?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Prospective%20derivation%20of%20a%20living%20organoid%20biobank%20of%20colorectal%20cancer%20patients&journal=Cell&doi=10.1016%2Fj.cell.2015.03.053&volume=161&pages=933-45&publication_year=2015&author=Wetering%2CM&author=Francies%2CHE&author=Francis%2CJM&author=Bounova%2CG&author=Iorio%2CF&author=Pronk%2CA
- Explore the financials of https://doi.org/10.1038%2Fs41388-020-01492-9
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Molecular%20biological%20analysis%20of%205-FU-resistant%20gastric%20cancer%20organoids%3B%20KHDRBS3%20contributes%20to%20the%20attainment%20of%20features%20of%20cancer%20stem%20cell&journal=Oncogene&doi=10.1038%2Fs41388-020-01492-9&volume=39&pages=7265-78&publication_year=2020&author=Ukai%2CS&author=Honma%2CR&author=Sakamoto%2CN&author=Yamamoto%2CY&author=Pham%2CQT&author=Harada%2CK
- How much profit does https://doi.org/10.1074%2Fjbc.M802306200 generate?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=The%20endocytic%20recycling%20protein%20EHD2%20interacts%20with%20myoferlin%20to%20regulate%20myoblast%20fusion&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M802306200&volume=283&pages=20252-60&publication_year=2008&author=Doherty%2CKR&author=Demonbreun%2CAR&author=Wallace%2CGQ&author=Cave%2CA&author=Posey%2CAD&author=Heretis%2CK?
- Find out how much https://doi.org/10.1152%2Fajpcell.00498.2008 earns monthly
- How much profit does http://scholar.google.com/scholar_lookup?&title=Myoferlin%20is%20critical%20for%20endocytosis%20in%20endothelial%20cells&journal=Am%20J%20Physiol%20Cell%20Physiol&doi=10.1152%2Fajpcell.00498.2008&volume=297&pages=C484-C92&publication_year=2009&author=Bernatchez%2CPN&author=Sharma%2CA&author=Kodaman%2CP&author=Sessa%2CWC generate?
- https://doi.org/10.1093%2Fhmg%2F9.2.217's financial summary
- How much does http://scholar.google.com/scholar_lookup?&title=Myoferlin%2C%20a%20candidate%20gene%20and%20potential%20modifier%20of%20muscular%20dystrophy&journal=Hum%20Mol%20Genet&doi=10.1093%2Fhmg%2F9.2.217&volume=9&pages=217-26&publication_year=2000&author=Davis%2CDB&author=Delmonte%2CAJ&author=Ly%2CCT&author=McNally%2CEM generate monthly?
- What's the financial intake of https://doi.org/10.1242%2Fdev.02155?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Normal%20myoblast%20fusion%20requires%20myoferlin&journal=Development&doi=10.1242%2Fdev.02155&volume=132&pages=5565-75&publication_year=2005&author=Doherty%2CKR&author=Cave%2CA&author=Davis%2CDB&author=Delmonte%2CAJ&author=Posey%2CA&author=Earley%2CJU?
- How much revenue does https://doi.org/10.1242%2Fjcs.065375 generate?
- http://scholar.google.com/scholar_lookup?&title=Myoferlin%20regulation%20by%20NFAT%20in%20muscle%20injury%2C%20regeneration%20and%20repair&journal=J%20Cell%20Sci&doi=10.1242%2Fjcs.065375&volume=123&pages=2413-22&publication_year=2010&author=Demonbreun%2CAR&author=Lapidos%2CKA&author=Heretis%2CK&author=Levin%2CS&author=Dale%2CR&author=Pytel%2CP's total income per month
- Revenue of https://doi.org/10.1158%2F0008-5472.CAN-13-1142
- How much income is http://scholar.google.com/scholar_lookup?&title=Myoferlin%20is%20a%20key%20regulator%20of%20EGFR%20activity%20in%20breast%20cancer&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-13-1142&volume=73&pages=5438-48&publication_year=2013&author=Turtoi%2CA&author=Blomme%2CA&author=Bellahc%C3%A8ne%2CA&author=Gilles%2CC&author=Hennequi%C3%A8re%2CV&author=Peixoto%2CP earning monthly?
- How much does https://doi.org/10.1038%2Fs41467-018-06179-0 gross monthly?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=A%20small%20molecule%20targeting%20myoferlin%20exerts%20promising%20anti-tumor%20effects%20on%20breast%20cancer&journal=Nat%20Commun&doi=10.1038%2Fs41467-018-06179-0&volume=9&publication_year=2018&author=Zhang%2CT&author=Li%2CJ&author=He%2CY&author=Yang%2CF&author=Hao%2CY&author=Jin%2CW?
- What's http://scholar.google.com/scholar_lookup?&title=Japanese%20classification%20of%20gastric%20carcinoma%3A%203rd%20English%20edition&journal=Gastric%20Cancer&doi=10.1007%2Fs10120-011-0041-5&volume=14&pages=101-12&publication_year=2011's gross income?
- How much income is http://scholar.google.com/scholar_lookup?&title=Expression%20and%20function%20of%20Uc.%20160%2B%2C%20a%20transcribed%20ultraconserved%20region%2C%20in%20gastric%20cancer&journal=Gastric%20Cancer&doi=10.1007%2Fs10120-017-0714-9&volume=20&pages=960-9&publication_year=2017&author=Honma%2CR&author=Goto%2CK&author=Sakamoto%2CN&author=Sekino%2CY&author=Sentani%2CK&author=Oue%2CN earning monthly?
- Revenue of https://doi.org/10.1111%2Fcas.12330
- How much does http://scholar.google.com/scholar_lookup?&title=MicroRNA-148a%20is%20downregulated%20in%20gastric%20cancer%2C%20targets%20MMP7%2C%20and%20indicates%20tumor%20invasiveness%20and%20poor%20prognosis&journal=Cancer%20Sci&doi=10.1111%2Fcas.12330&volume=105&pages=236-43&publication_year=2014&author=Sakamoto%2CN&author=Naito%2CY&author=Oue%2CN&author=Sentani%2CK&author=Uraoka%2CN&author=Oo%2CHZ bring in each month?
- How much profit does https://doi.org/10.1016%2Fj.devcel.2018.02.013 make?
- How much does http://scholar.google.com/scholar_lookup?&title=APC%20inhibits%20ligand-independent%20Wnt%20signaling%20by%20the%20clathrin%20endocytic%20pathway&journal=Dev%20Cell&doi=10.1016%2Fj.devcel.2018.02.013&volume=44&pages=566-81.e8&publication_year=2018&author=Saito-Diaz%2CK&author=Benchabane%2CH&author=Tiwari%2CA&author=Tian%2CA&author=Li%2CB&author=Thompson%2CJJ net monthly?
- What's the financial outcome of https://doi.org/10.18632%2Foncotarget.21688?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Transcribed%20ultraconserved%20region%20Uc.%2063%2B%20promotes%20resistance%20to%20docetaxel%20through%20regulation%20of%20androgen%20receptor%20signaling%20in%20prostate%20cancer&journal=Oncotarget&doi=10.18632%2Foncotarget.21688&volume=8&pages=94259-70&publication_year=2017&author=Sekino%2CY&author=Sakamoto%2CN&author=Goto%2CK&author=Honma%2CR&author=Shigematsu%2CY&author=Sentani%2CK
- What's the income of https://doi.org/10.1111%2Fj.1349-7006.2012.02353.x?
- How much does http://scholar.google.com/scholar_lookup?&title=Liver-intestine%20cadherin%20induction%20by%20epidermal%20growth%20factor%20receptor%20is%20associated%20with%20intestinal%20differentiation%20of%20gastric%20cancer&journal=Cancer%20Sci&doi=10.1111%2Fj.1349-7006.2012.02353.x&volume=103&pages=1744-50&publication_year=2012&author=Sakamoto%2CN&author=Oue%2CN&author=Sentani%2CK&author=Anami%2CK&author=Uraoka%2CN&author=Naito%2CY rake in every month?
- https://doi.org/10.1038%2Fnature07935's financial summary
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Single%20Lgr5%20stem%20cells%20build%20crypt-villus%20structures%20in%20vitro%20without%20a%20mesenchymal%20niche&journal=Nature&doi=10.1038%2Fnature07935&volume=459&pages=262-5&publication_year=2009&author=Sato%2CT&author=Vries%2CRG&author=Snippert%2CHJ&author=Wetering%2CM&author=Barker%2CN&author=Stange%2CDE have monthly?
- Explore the financials of https://doi.org/10.1038%2Fs41419-018-1236-z
- How much profit does http://scholar.google.com/scholar_lookup?&title=ATXN2L%20upregulated%20by%20epidermal%20growth%20factor%20promotes%20gastric%20cancer%20cell%20invasiveness%20and%20oxaliplatin%20resistance&journal=Cell%20Death%20Dis&doi=10.1038%2Fs41419-018-1236-z&volume=10&pages=1-13&publication_year=2019&author=Lin%2CL&author=Li%2CX&author=Pan%2CC&author=Lin%2CW&author=Shao%2CR&author=Liu%2CY generate?
- How much does https://doi.org/10.18632%2Foncotarget.18208 pull in?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=EphA2%20affects%20the%20sensitivity%20of%20oxaliplatin%20by%20inducing%20EMT%20in%20oxaliplatin-resistant%20gastric%20cancer%20cells&journal=Oncotarget&doi=10.18632%2Foncotarget.18208&volume=8&pages=47998-8011&publication_year=2017&author=Wen%2CQ&author=Chen%2CZ&author=Chen%2CZ&author=Chen%2CJ&author=Wang%2CR&author=Huang%2CC generate?
- Learn about the earnings of https://doi.org/10.1038%2Fonc.2016.369
- http://scholar.google.com/scholar_lookup?&title=Myoferlin%20regulates%20cellular%20lipid%20metabolism%20and%20promotes%20metastases%20in%20triple-negative%20breast%20cancer&journal=Oncogene&doi=10.1038%2Fonc.2016.369&volume=36&pages=2116-30&publication_year=2017&author=Blomme%2CA&author=Costanza%2CB&author=Tullio%2CP&author=Thiry%2CM&author=Simaeys%2CG&author=Boutry%2CS's financial summary
- What's the total monthly financial gain of https://doi.org/10.1111%2Fjcmm.13455?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Down-regulating%20myoferlin%20inhibits%20the%20vasculogenic%20mimicry%20of%20melanoma%20via%20decreasing%20MMP-2%20and%20inducing%20mesenchymal-to-epithelial%20transition&journal=J%20Cell%20Mol%20Med&doi=10.1111%2Fjcmm.13455&volume=22&pages=1743-54&publication_year=2018&author=Zhang%2CW&author=Zhou%2CP&author=Meng%2CA&author=Zhang%2CR&author=Zhou%2CY?
- How much revenue does https://doi.org/10.1158%2F1535-7163.MCT-14-0636 produce monthly?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Tumor-related%20molecular%20mechanisms%20of%20oxaliplatin%20resistance&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-14-0636&volume=14&pages=1767-76&publication_year=2015&author=Martinez-Balibrea%2CE&author=Mart%C3%ADnez-Card%C3%BAs%2CA&author=Gin%C3%A9s%2CA&author=Ruiz%20de%20Porras%2CV&author=Moutinho%2CC&author=Layos%2CL
- Income figures for https://doi.org/10.1124%2Fmol.58.5.920
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Oxaliplatin-induced%20damage%20of%20cellular%20DNA&journal=Mol%20Pharmacol&doi=10.1124%2Fmol.58.5.920&volume=58&pages=920-27&publication_year=2000&author=Woynarowski%2CJM&author=Faivre%2CS&author=Herzig%2CMC&author=Arnett%2CB&author=Chapman%2CWG&author=Trevino%2CAV produce monthly?
- How much revenue does https://doi.org/10.1038%2Fnm.4291 produce monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=A%20subset%20of%20platinum-containing%20chemotherapeutic%20agents%20kills%20cells%20by%20inducing%20ribosome%20biogenesis%20stress&journal=Nat%20Med&doi=10.1038%2Fnm.4291&volume=23&pages=461-71&publication_year=2017&author=Bruno%2CPM&author=Liu%2CY&author=Park%2CGY&author=Murai%2CJ&author=Koch%2CCE&author=Eisen%2CTJ produce monthly?
- How much profit does https://doi.org/10.1016%2Fj.bcp.2009.12.002 generate?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Increased%20levels%20and%20defective%20glycosylation%20of%20MRPs%20in%20ovarian%20carcinoma%20cells%20resistant%20to%20oxaliplatin&journal=Biochem%20Pharmacol&doi=10.1016%2Fj.bcp.2009.12.002&volume=79&pages=1108-17&publication_year=2010&author=Beretta%2CGL&author=Benedetti%2CV&author=Cossa%2CG&author=Assaraf%2CYG&author=Bram%2CE&author=Gatti%2CL
- What's the income generated by https://citation-needed.springer.com/v2/references/10.1007/s10120-021-01206-4?format=refman&flavour=references each month?
- What's the total monthly financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kenji%20Harada?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kenji%20Harada%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Naoya%20Sakamoto bring in?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Naoya%20Sakamoto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shoichi%20Ukai income
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shoichi%20Ukai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yusuke%20Yamamoto's total income per month
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yusuke%20Yamamoto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Quoc%20Thang%20Pham?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Quoc%20Thang%20Pham%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Check the income stats for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Daiki%20Taniyama
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Daiki%20Taniyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ririno%20Honma?
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ririno%20Honma%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ryota%20Maruyama generate?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ryota%20Maruyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Tsuyoshi%20Takashima?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Tsuyoshi%20Takashima%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hiroshi%20Ota
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hiroshi%20Ota%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yuki%20Takemoto generate?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yuki%20Takemoto%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kazuaki%20Tanabe
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kazuaki%20Tanabe%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Hideki%20Ohdan's revenue stream
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Hideki%20Ohdan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wataru%20Yasui?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wataru%20Yasui%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://static-content.springer.com/esm/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_MOESM1_ESM.xlsx pull in monthly?
- See how much https://static-content.springer.com/esm/art%3A10.1007%2Fs10120-021-01206-4/MediaObjects/10120_2021_1206_MOESM2_ESM.pdf makes per month
- Get to know https://s100.copyright.com/AppDispatchServlet?title=Establishment%20of%20oxaliplatin-resistant%20gastric%20cancer%20organoids%3A%20importance%20of%20myoferlin%20in%20the%20acquisition%20of%20oxaliplatin%20resistance&author=Kenji%20Harada%20et%20al&contentID=10.1007%2Fs10120-021-01206-4©right=The%20International%20Gastric%20Cancer%20Association%20and%20The%20Japanese%20Gastric%20Cancer%20Association&publication=1436-3291&publicationDate=2021-07-16&publisherName=SpringerNature&orderBeanReset=true's earnings
- Explore the financials of https://crossmark.crossref.org/dialog/?doi=10.1007/s10120-021-01206-4
- How much does https://citation-needed.springer.com/v2/references/10.1007/s10120-021-01206-4?format=refman&flavour=citation gross monthly?
- How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral earn?
- https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's financial summary
- How much profit does https://www.springernature.com/gp/products generate?
- Find out how much https://www.springernature.com/gp/librarians earns monthly
- What's the financial intake of https://www.springernature.com/gp/societies?
- How much does https://www.springernature.com/gp/partners pull in?
- What's the profit of https://www.springer.com/?
- Discover the revenue of https://www.nature.com/
- Revenue of https://www.biomedcentral.com/
- Learn how profitable https://www.palgrave.com/ is on a monthly basis
- Explore the financials of https://www.apress.com/
- How much does https://www.springernature.com/gp/legal/ccpa earn?
- How much does https://www.springernature.com/gp/info/accessibility earn?
- What's the income generated by https://support.springernature.com/en/support/home each month?
- Get to know what's the income of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- How much does https://www.springernature.com/ make?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref